Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

Abroad (travel likely)Recruiting

Conditions

Systemic Sclerosis (SSc) · Hand Dysfunction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NanFang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Contact: Study coordinator (NanFang Hospital of Southern Medical University) · nfyyec@163.com · 020-62787238
Huashan Hospital Fudan University, Shanghai, China
Contact: Study coordinator (Huashan Hospital Fudan University) · licaihong199505@163.com · 021-52888045

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Los Angeles, United States

Systemic Sclerosis DIet for GastrointESTinal Symptoms

Systemic Sclerosis (SSc)

Abroad (travel likely)Recruiting

Ann Arbor, United States

A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

Systemic Sclerosis

Abroad (travel likely)RecruitingPHASE3

Scottsdale, United States · Aurora, United States

US Zamto-cel Autoimmune Diseases

Lupus Nephritis · Systemic Lupus Erythematosus · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States